Studies with two new phosphodiesterase inhibitors (ICI 58, 301 and ICI 63, 197) on anaphylaxis in guinea pigs, mice and rats.
D000081:Acetamides / Q000494:pharmacology; D000707:Anaphylaxis; D000818:Animals; D000242:Cyclic AMP; D005620:Freund's Adjuvant; D005856:Germ-Free Life; D006168:Guinea Pigs; D007106:Immune Sera; D007073:Immunoglobulin E / Q000032:analysis; D008168:Lung / Q000276:immunology; D051379:Mice; D010047:Ovalbumin; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D010567:Pertussis Vaccine; D010726:Phosphodiesterase Inhibitors; D011234:Precipitins / Q000032:analysis; D011719:Pyrazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D014230:Triazoles / Q000494:pharmacology
D000081:Acetamides; D007106:Immune Sera; D010567:Pertussis Vaccine; D010726:Phosphodiesterase Inhibitors; D011234:Precipitins; D011719:Pyrazines; D011743:Pyrimidines; D014230:Triazoles; D007073:Immunoglobulin E; D010047:Ovalbumin; D005620:Freund's Adjuvant; D000242:Cyclic AMP